Search Tag: anticoagulants

2021 23 Nov

This review focuses on different techniques to reverse direct oral anticoagulants,  either with specific or non-specific agents. D irect oral anticoagulants (DOACs) are now standing for Vitamin K antagonists in many clinical settings. They are recognised as a major step forward for our patients. Their efficacy has been confirmed...Read more

2019 26 Sep

Specific treatment options for factor Xa inhibitor-related bleeding, focusing on drugs like rivaroxaban, apixaban, and edoxaban.   Non-vitamin K oral anticoagulants (NOACs/DOACs) are direct reversible inhibitors of factor Xa. These drugs are also reversible inhibitors versus warfarin or other vitamin K antagonist that are used in Europe. Anticoagulants...Read more

2018 03 Apr

A new study compared outcomes among patients with atrial fibrillation hospitalised for bleeding after starting anticoagulation (warfarin, dabigatran, or rivaroxaban). Results show rivaroxaban and dabigatran were associated with shorter hospitalisations; however, there were no differences in 30- and 90-day mortality. These findings suggest bleeding...Read more

2015 01 Oct

A panel of experts (InterEPID) has released a new Canadian guideline for the diagnosis and management of blood clots, specifically iliofemoral deep vein thrombosis (DVT), in the groin and thigh. The guideline, published in CMAJ (Canadian Medical Association Journal), was developed by a team of haematologists, vascular surgeons, interventional radiologists,...Read more